Direct or Subacute Coronary Angiography in Patients With Out of Hospital Cardiac Arrest Without Coma.
Launched by AARHUS UNIVERSITY HOSPITAL SKEJBY · May 4, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best timing for a medical procedure called angiography in patients who have experienced a cardiac arrest outside of a hospital. Angiography is a test that helps doctors see the blood vessels in the heart to check for blockages. The researchers want to find out if doing this test right away (within 2 hours) is better than waiting 12 to 24 hours after the patient has regained a normal heartbeat, known as Return of Spontaneous Circulation (ROSC).
To participate in this trial, patients need to have had a witnessed cardiac arrest, meaning someone saw it happen, and they must have regained their heartbeat. They also need to be assessed within a certain time frame and have a good level of consciousness after the event. Unfortunately, people under 18, those with a clear non-heart-related cause for the cardiac arrest, or those with severe health issues are not eligible. Participants will undergo the angiography procedure, and their outcomes will help doctors understand the best approach to take in these urgent situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Witnessed Cardiac Arrest
- • ROSC
- • CAG possible within 120 minutes
- • Glasgow coma scale \>8
- Exclusion Criteria:
- • Age \< 18 years
- • Obvious non-cardiac cause for the arrest
- • Terminal illness
- • STEMI
About Aarhus University Hospital Skejby
Aarhus University Hospital Skejby is a leading medical institution in Denmark, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pivotal part of the Aarhus University Health, the hospital specializes in a wide range of medical fields, fostering collaboration between clinicians and researchers to enhance patient outcomes. With state-of-the-art facilities and a multidisciplinary approach, Aarhus University Hospital Skejby is dedicated to conducting high-quality clinical trials that contribute to the development of new therapies and medical advancements, ensuring the highest standards of patient care and safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Odense, , Denmark
Aalborg, , Denmark
Aarhus, , Denmark
Nijmegen, , Netherlands
Aarhus, , Denmark
Eindhoven, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials